Gary Taylor
Stock Analyst at TD Cowen
(2.58)
# 2,291
Out of 5,012 analysts
148
Total ratings
51.52%
Success rate
0.78%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $44 → $25 | $27.23 | -8.19% | 5 | Aug 7, 2025 | |
| BBWI Bath & Body Works | Maintains: Buy | $40 → $42 | $25.68 | +63.55% | 2 | Nov 26, 2024 | |
| PIII P3 Health Partners | Maintains: Hold | $45 → $13 | $9.02 | +38.64% | 2 | Nov 20, 2024 | |
| AGL agilon health | Maintains: Hold | $6 → $2 | $1.06 | +88.68% | 4 | Nov 11, 2024 | |
| HUM Humana | Maintains: Hold | $261 → $268 | $295.25 | -9.23% | 20 | Nov 4, 2024 | |
| ALHC Alignment Healthcare | Maintains: Buy | $10 → $13 | $16.98 | -23.44% | 6 | Oct 31, 2024 | |
| HCA HCA Healthcare | Maintains: Buy | $450 → $440 | $437.57 | +0.56% | 9 | Oct 28, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $601 → $609 | $363.66 | +67.46% | 4 | Oct 18, 2024 | |
| CNC Centene | Maintains: Buy | $80 → $89 | $38.42 | +131.65% | 10 | Jul 31, 2024 | |
| MOH Molina Healthcare | Maintains: Buy | $351 → $378 | $203.26 | +85.97% | 18 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $183 → $220 | $209.70 | +4.91% | 12 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $139 → $150 | $131.04 | +14.47% | 11 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $26 | $24.02 | +8.24% | 5 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $39 → $35 | $20.39 | +71.65% | 2 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $564 → $585 | $357.49 | +63.64% | 2 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $6 | $22.47 | -73.30% | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $8 | $5.53 | +44.67% | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $242 → $329 | $307.14 | +7.12% | 3 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $7 → $3 | $2.70 | +11.11% | 4 | Feb 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $5.21 | +226.30% | 1 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $28 → $20 | $204.83 | -90.24% | 12 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $20 | $17.60 | +13.64% | 6 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.13 | - | 6 | Dec 14, 2017 |
Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44 → $25
Current: $27.23
Upside: -8.19%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $25.68
Upside: +63.55%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45 → $13
Current: $9.02
Upside: +38.64%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6 → $2
Current: $1.06
Upside: +88.68%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261 → $268
Current: $295.25
Upside: -9.23%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10 → $13
Current: $16.98
Upside: -23.44%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450 → $440
Current: $437.57
Upside: +0.56%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601 → $609
Current: $363.66
Upside: +67.46%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80 → $89
Current: $38.42
Upside: +131.65%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351 → $378
Current: $203.26
Upside: +85.97%
Jul 26, 2024
Maintains: Hold
Price Target: $183 → $220
Current: $209.70
Upside: +4.91%
Jul 24, 2024
Maintains: Hold
Price Target: $139 → $150
Current: $131.04
Upside: +14.47%
Mar 1, 2024
Maintains: Outperform
Price Target: $30 → $26
Current: $24.02
Upside: +8.24%
Nov 14, 2023
Upgrades: Outperform
Price Target: $39 → $35
Current: $20.39
Upside: +71.65%
Jul 24, 2023
Maintains: Outperform
Price Target: $564 → $585
Current: $357.49
Upside: +63.64%
Feb 14, 2023
Maintains: Market Perform
Price Target: $3 → $6
Current: $22.47
Upside: -73.30%
Nov 14, 2022
Maintains: Outperform
Price Target: $10 → $8
Current: $5.53
Upside: +44.67%
May 9, 2022
Upgrades: Outperform
Price Target: $242 → $329
Current: $307.14
Upside: +7.12%
Feb 2, 2022
Upgrades: Market Perform
Price Target: $7 → $3
Current: $2.70
Upside: +11.11%
Sep 10, 2021
Initiates: Market Perform
Price Target: $17
Current: $5.21
Upside: +226.30%
Sep 21, 2020
Downgrades: Underweight
Price Target: $28 → $20
Current: $204.83
Upside: -90.24%
Feb 24, 2020
Maintains: Neutral
Price Target: $33 → $20
Current: $17.60
Upside: +13.64%
Dec 14, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.13
Upside: -